Status:
COMPLETED
Combined CBIT and rTMS to Improve Tourette's Syndrome
Lead Sponsor:
University of Florida
Conditions:
Tourette Syndrome
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The investigator will apply 16 sessions of repetitive transcranial magnetic stimulation (rTMS) over 4 consecutive days for adult patients suffering from Tourette's Syndrome. Following rTMS, patients w...
Detailed Description
Patients will be randomly assigned to active or sham stimulation, with 10 in each group, followed by 10 weeks of tele-CBIT. Patients will have primary and secondary outcome measures performed at four ...
Eligibility Criteria
Inclusion
- Any patient diagnosed with Tourette Syndrome \> 18 years of age with moderate tic severity.
- Participants will be allowed to continue oral medications that they are taking for TS concurrently but will not be allowed to change their concurrent medication regimen throughout the duration of the study
Exclusion
- Presence of metallic objects or neurostimulators in the brain
- Pregnancy
- History of active seizures or epilepsy
- Contraindications to receiving fMRI, such as claustrophobia
- Inability to participate in CBIT due to other underlying cognitive or medical condition
Key Trial Info
Start Date :
December 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 18 2023
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT04795908
Start Date
December 17 2021
End Date
January 18 2023
Last Update
April 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fixel Neurologic Institute
Gainesville, Florida, United States, 32608